BAUS oncology guidance for implementing streamlining in cancer MDT meetings: Selecting standards of care and operational considerations

被引:2
作者
Lamb, Benjamin W. [1 ,2 ,5 ]
Linton, Kate D. [3 ]
Narahari, Krishna [4 ]
机构
[1] Barts Hlth NHS Trust, Dept Urol, London, England
[2] Univ Coll Hosp, NHS Fdn Trust, Dept Urol, London, England
[3] Chesterfield Royal Hosp, NHS Fdn Trust, Dept Urol, Calow, England
[4] Univ Hosp Wales, Cardiff, England
[5] Barts Hlth NHS Trust, Dept Urol, Whitechapel Rd, London EC1 1BB, England
关键词
Multidisciplinary team; streamlining; cancer; standards of care; urology;
D O I
10.1177/20514158231168463
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
It is widely recognised that multidisciplinary team meetings (MDTMs) are the cornerstone of cancer practice in the United Kingdom and many countries around the world. While MDTMs offer several key benefits to patients, healthcare professionals and cancer registration, data and audit services, in the United Kingdom they have over time become too large, onerous and 'transactional' often discussing cases that have a pre-determined management plan. In response to this growing problem, National Health Service (NHS) England and NHS Improvement produced an multidisciplinary team (MDT) streamlining document as a guide to encourage MDTM to consider a 'Standard of Care' (SoC) approach to conditions with a predictable agreed management plan based on national, regional cancer network or local cancer unit protocols. This would then enable more meaningful discussion of complex cases with in the MDT. This document did not gain much traction and had little impact on UK urological cancer MDTM. As a result, The British Association of Urological Surgeons (BAUS) was approached by the NHS Getting It Right First Time (GIRFT) Leads in 2021 to promote an SoC-based streamlining to urological cancer MDT working. Having consulted widely with colleagues, cancer networks and cancer delivery teams, the BAUS Section of Oncology sought views from its membership during a dedicated MDTM session in the Sections of Oncology Meeting, December 2021. From this extensive engagement with stakeholders, we have put together the following guidance for use as a framework to facilitate the agreement of local policies in the interests of supporting the needs of patients and MDTs.
引用
收藏
页码:438 / 442
页数:5
相关论文
共 14 条
  • [1] Cancer Research UK, 2017, IMPROVING EFFECTIVEN
  • [2] Gore M., 2017, TRANSF MULT TEAM M M
  • [3] Harrison S, 2018, UROLOGY GIRFT PROGRA
  • [4] Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women
    Kesson, Eileen M.
    Allardice, Gwen M.
    George, W. David
    Burns, Harry J. G.
    Morrison, David S.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [5] Quality of Care Management Decisions by Multidisciplinary Cancer Teams: A Systematic Review
    Lamb, Benjamin W.
    Brown, Katrina F.
    Nagpal, Kamal
    Vincent, Charles
    Green, James S. A.
    Sevdalis, Nick
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (08) : 2116 - 2125
  • [6] National Institute for Health Care Excellence, 2019, NICE GUID NG131
  • [7] National Institute for Health Care Excellence, 2015, NICE GUID NG2
  • [8] National Institute for Health Care Excellence, 2002, IMPR OUTC GUID IOG
  • [9] NHS England and NHS Improvement, 2020, STREAML MULT TEAM M
  • [10] A measure of case complexity for streamlining workflow in multidisciplinary tumor boards: Mixed methods development and early validation of the MeDiC tool
    Soukup, Tayana
    Morbi, Abigail
    Lamb, Benjamin W.
    Gandamihardja, Tasha A. K.
    Hogben, Katy
    Noyes, Katia
    Skolarus, Ted A.
    Darzi, Ara
    Sevdalis, Nick
    Green, James S. A.
    [J]. CANCER MEDICINE, 2020, 9 (14): : 5143 - 5154